post semaglutide side effects Ozempic (semaglutide) is a GLP-1 receptor agonist used for type 2 diabetes (and sometimes weight loss). Its range from common GI symptoms to rare but serious risks. ⸻ 🟡 Common Your guide to GLP-1 side

Phase 3 Results (REIMAGINE-2, Feb 2026): HbA1c reduction of up to 1.91 points, outperforming semaglutide alone Weight loss of up to 14.2% at 68 weeks in adults with type 2 diabetes and obesity In weight-management evaluation, diabetics achieved ~15.7% weight loss vs 3.1% with placebo Regulatory update: Novo Nordisk filed for FDA approval (Dec 2025) for weight management, supported by the REDEFINE clinical program

Businessman Mark Cuban has a seemingly straightforward question for the huge drug middleman owned by CVS: If you're as transparent about drug pricing as you claim, why don't you publish prices on your website

Reassessments and adjustments were made as appropriate

Home Medical Weight Loss at Gig Harbor Medical Spa & Concierge Medicine A Smarter, Safer, Medically Guided Approach to Weight Loss At Gig Harbor Medical Spa & Concierge Medicine, we offer a comprehensive, medically supervised weight loss program designed to help you lose weight safely, preserve muscle, and create lasting results

Compounded GLP-1 + GIP for weight loss

Use our free Retatrutide dosage Calculator to find accurate trial-based dosages